Ohcanbohtosat - Hugo Cheinquer
- Čájehuvvo 1 - 20 / 57
- Sirdás čuovvovaš siidui
-
1
Treatment of chronic hepatitis C virus infection in the near future Dahkki Hugo Cheinquer
Almmustuhtton 2013Editorial -
2
-
3
-
4
Prevalence of hepatitis C virus infection in patients with COPD Dahkki D. R. Silva, Jonathas Stifft, Hugo Cheinquer, Marli Maria Knorst
Almmustuhtton 2009Artigo -
5
-
6
-
7
Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil Dahkki Fabio MR Barros, Hugo Cheinquer, C.T. Tsuchiya, E.A.V. Santos
Almmustuhtton 2013Artigo -
8
Antibiotics for hepatic encephalopathy Dahkki Maicon Falavigna, Christian Kieling, Fernando Herz Wolff, Lídia RF Medeiros, Hugo Cheinquer
Almmustuhtton 2017Artigo -
9
Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin Dahkki Silvia Coelho-Borges, Hugo Cheinquer, Fernando Herz Wolff, Nelson Cheinquer, Luciano Krug, Patrícia Ashton‐Prolla
Almmustuhtton 2012Artigo -
10
DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS? Dahkki Marcela Laurito, Giovanni Faria Silva, Hugo Cheinquer, Rajani Sharma, Elizabeth C. Verna, Edison Roberto Parise
Almmustuhtton 2018Artigo -
11
-
12
-
13
P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS Dahkki Hugo Cheinquer, Fábia Benetti, Alexandre de Araújo, Italo de Maman, Cristina Cheinquer Coelho Borges, Fernando Wolff Herz
Almmustuhtton 2023Artigo -
14
Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals Dahkki Fábia Benetti, Alexandre de Araújo, Italo de Maman, Cristina Coelho Borges Cheinquer, Fernando Herz Wolff, Hugo Cheinquer
Almmustuhtton 2024Artigo -
15
P2-76 Antibiotics for hepatic encephalopathy: systematic review of randomised controlled trials Dahkki Maicon Falavigna, Carlos Oscar Kieling, Fernando Herz Wolff, Lídia Rosi Medeiros, Leonardo Alves, Hugo Cheinquer, Bruce Bartholow Duncan
Almmustuhtton 2011Artigo -
16
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C Dahkki Robert Flisiak, Mitchell L. Shiffman, Juan Arenas, Hugo Cheinquer, И. Г. Никитин, Yuping Dong, Khurram Rana, Subasree Srinivasan
Almmustuhtton 2016Artigo -
17
Hepatic steatosis among people living with HIV in Southern Brazil: prevalence and risk factors Dahkki Marina Ferri Pezzini, Hugo Cheinquer, Alexandre de Araújo, Carlos T. Schmidt-Cerski, Eduardo Sprinz, Fernando Herz-Wolff, Júlia Poeta
Almmustuhtton 2020Artigo -
18
-
19
-
20
The use of ustekinumab in a patient with severe psoriasis and positive HBV serology Dahkki Raquel Bissacotti Steglich, Luana Pizarro Meneghello, André Vicente Esteves de Carvalho, Hugo Cheinquer, Fernanda Melo Müller, Flávia Pereira Reginatto
Almmustuhtton 2014Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Virus
Gastroenterology
Hepatitis C
Hepatitis C virus
Immunology
Virology
Cirrhosis
Ribavirin
Hepatocellular carcinoma
Environmental health
Adverse effect
Viral load
Chronic hepatitis
Liver disease
Population
Biology
Disease
Hepatitis B
Hepatitis B virus
Intensive care medicine
Randomized controlled trial
Antiretroviral therapy
Gene
Confidence interval
Dasabuvir
Discontinuation
Genotype
HBsAg